Guggenheim Capital LLC Regeneron Pharmaceuticals, Inc. Transaction History

Guggenheim Capital LLC

  • $14 Billion
  • Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Guggenheim Capital LLC holds 38,364 shares of REGN stock, worth $27.4 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
38,364
Previous 43,592 11.99%
Holding current value
$27.4 Million
Previous $45.8 Million 11.98%
% of portfolio
0.29%
Previous 0.33%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$1024.09 - $1201.76 $5.35 Million - $6.28 Million
-5,228 Reduced 11.99%
38,364 $40.3 Million
Q2 2024

Aug 14, 2024
BUY
$883.2 - $1071.19 $1.98 Million - $2.4 Million
2,239 Added 5.41%
43,592 $45.8 Million
Q1 2024

May 14, 2024
SELL
$902.69 - $993.35 $1.44 Million - $1.58 Million
-1,591 Reduced 3.7%
41,353 $39.8 Million
Q4 2023

Feb 14, 2024
BUY
$775.18 - $881.7 $2.64 Million - $3 Million
3,403 Added 8.61%
42,944 $37.7 Million
Q3 2023

Nov 14, 2023
BUY
$692.45 - $844.37 $632,206 - $770,909
913 Added 2.36%
39,541 $32.5 Million
Q2 2023

Aug 11, 2023
SELL
$700.03 - $830.35 $2.34 Million - $2.77 Million
-3,337 Reduced 7.95%
38,628 $27.8 Million
Q1 2023

May 10, 2023
SELL
$680.49 - $826.97 $5.5 Million - $6.69 Million
-8,087 Reduced 16.16%
41,965 $34.5 Million
Q4 2022

Feb 14, 2023
SELL
$705.89 - $766.39 $3.15 Million - $3.42 Million
-4,463 Reduced 8.19%
50,052 $36.1 Million
Q3 2022

Nov 14, 2022
SELL
$573.97 - $724.32 $4.7 Million - $5.94 Million
-8,197 Reduced 13.07%
54,515 $37.6 Million
Q2 2022

Aug 15, 2022
SELL
$548.35 - $738.84 $2.24 Million - $3.01 Million
-4,079 Reduced 6.11%
62,712 $37.1 Million
Q1 2022

May 16, 2022
SELL
$595.12 - $698.43 $6.45 Million - $7.58 Million
-10,846 Reduced 13.97%
66,791 $46.6 Million
Q4 2021

Feb 14, 2022
BUY
$543.48 - $670.97 $3.89 Million - $4.81 Million
7,166 Added 10.17%
77,637 $49 Million
Q3 2021

Nov 15, 2021
SELL
$574.03 - $680.96 $5.15 Million - $6.11 Million
-8,973 Reduced 11.29%
70,471 $42.6 Million
Q2 2021

Aug 13, 2021
BUY
$472.8 - $558.54 $5.36 Million - $6.34 Million
11,343 Added 16.66%
79,444 $44.4 Million
Q1 2021

May 13, 2021
BUY
$446.73 - $548.2 $1.32 Million - $1.62 Million
2,951 Added 4.53%
68,101 $32.2 Million
Q4 2020

Feb 16, 2021
SELL
$478.3 - $607.98 $33,481 - $42,558
-70 Reduced 0.11%
65,150 $31.5 Million
Q3 2020

Nov 13, 2020
SELL
$544.75 - $658.21 $2.44 Million - $2.95 Million
-4,481 Reduced 6.43%
65,220 $36.5 Million
Q2 2020

Aug 14, 2020
SELL
$493.32 - $643.92 $2.77 Million - $3.62 Million
-5,619 Reduced 7.46%
69,701 $43.5 Million
Q1 2020

Jun 02, 2020
SELL
$336.18 - $494.43 $4.77 Million - $7.01 Million
-14,185 Reduced 15.85%
75,320 $36.8 Million
Q4 2019

Feb 14, 2020
BUY
$274.13 - $376.51 $193,535 - $265,816
706 Added 0.8%
89,505 $33.6 Million
Q3 2019

Nov 14, 2019
BUY
$273.46 - $318.39 $5.13 Million - $5.97 Million
18,763 Added 26.79%
88,799 $24.6 Million
Q2 2019

Aug 14, 2019
BUY
$299.6 - $414.82 $841,276 - $1.16 Million
2,808 Added 4.18%
70,036 $21.9 Million
Q1 2019

May 15, 2019
BUY
$372.08 - $439.57 $2.27 Million - $2.68 Million
6,107 Added 9.99%
67,228 $27.6 Million
Q4 2018

Feb 14, 2019
SELL
$335.82 - $403.04 $3.49 Million - $4.19 Million
-10,401 Reduced 14.54%
61,121 $22.8 Million
Q3 2018

Nov 14, 2018
SELL
$351.14 - $408.51 $848,354 - $986,960
-2,416 Reduced 3.27%
71,522 $28.9 Million
Q2 2018

Aug 14, 2018
SELL
$284.6 - $344.99 $41.5 Million - $50.3 Million
-145,747 Reduced 66.34%
73,938 $25.5 Million
Q1 2018

May 15, 2018
BUY
$315.82 - $393.78 $742,808 - $926,170
2,352 Added 1.08%
219,685 $75.7 Million
Q4 2017

Feb 14, 2018
BUY
$358.63 - $469.95 $20.4 Million - $26.7 Million
56,829 Added 35.41%
217,333 $81.7 Million
Q3 2017

Nov 14, 2017
BUY
$431.38 - $504.0 $69.2 Million - $80.9 Million
160,504
160,504 $71.8 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Guggenheim Capital LLC Portfolio

Follow Guggenheim Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email